POPULARITY
13 episodes with patient recruitment
7 episodes with patient recruitment
5 episodes with patient recruitment
2 episodes with patient recruitment
2 episodes with patient recruitment
2 episodes with patient recruitment
4 episodes with patient recruitment
2 episodes with patient recruitment
2 episodes with patient recruitment
Patient recruitment continues to be a major cost driver and top challenge in clinical research. More than half of sites have to pay recruitment expenses out of their own funds, as sponsor budgets won't cover some of necessary education and recruitment practices that sites must perform in order to meet enrollment goals and stay in business. This ‘Enabling Successful Sites' podcast episode, moderated by Karen McIntyre, Vice President, Global Site Alliances with insights from Steve Sattik, recently retired, former EVP at Flourish Research and Leslie Ives, Senior Director, Patient Recruitment at Parexel, discusses the challenges sites face with patient recruitment, the need for close collaboration between sites, sponsors and CROs, and flexible options that satisfy all parties.
AI is becoming increasingly prevalent in the healthcare industry and clinical research. For clinical trial recruitment, AI can be extremely helpful in finding potential patient volunteers as well improving overall retention rates. In part two of this ‘Enabling Successful Sites' podcast episode on improving patient recruitment and retention, Karen McIntyre, Vice President, Global Site Alliances, Steve Sattik, recently retired, former EVP at Flourish Research and Leslie Ives, Senior Director, Patient Recruitment at Parexel, discuss how we can leverage AI today to improve patient recruitment and retention and how they see AI evolving recruitment practices in the future.
Hemogenyx Pharmaceuticals PLC CEO Dr Vladislav Sandler talked with Proactive's Stephen Gunnion about a significant milestone for the company: the opening of its first clinical trial site and the commencement of patient recruitment for its lead drug, HG-CT-1. This Phase 1 trial is designed to evaluate the safety profile of HG-CT-1, a CAR-T therapy aimed at treating relapsed and refractory acute myeloid leukaemia (AML) in adult patients. Sandler highlighted the trial's objectives, which include assessing the therapy's efficacy based on AML-specific response criteria, overall survival, progression-free survival, and duration of response. He emphasised that this trial represents a major step forward in offering hope to patients with limited treatment options. The trial is being conducted at a top-tier cancer research institution in the United States. Discussing future plans, Sandler revealed that the company intends to expand trials to include pediatric patients with AML and acute lymphoblastic leukaemia, as well as patients suffering from the rare blood disease BPDCN. These efforts underline Hemogenyx's commitment to revolutionizing treatments for these conditions. Stay tuned for more updates on Proactive's YouTube channel. Don't forget to like this video, subscribe to our channel, and enable notifications for future content. #HemogenyxPharmaceuticals #CAR-TTherapy #AMLResearch #CancerTreatment #ClinicalTrials #BiotechNews #HealthcareInnovation #ProactiveUpdates #Phase1Trials #proactiveinvestors
As the biopharma industry strives to ensure that clinical trials reflect the rich diversity of the patient populations they aim to serve, the challenges to make this possible have fallen on the trial sites. In a recent webinar, Syneos Health experts Jane Bentley and Juliette Roberts from our Oncology Therapeutic Strategy & Innovation team, and Kelli Defenbaugh from Patient Recruitment and Retention Management, offered robust strategies and actionable insights tailored to overcome obstacles sites are facing.Listen in to learn more about how sites can contribute to enhanced diversity in oncology trials, with specific actions that sites can take to make each clinical trial better represent the population it seeks to serve.Visit here for more oncology insights from our experts.The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at insightshub.health. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Artificial intelligence (AI) has the potential to revolutionize clinical trials, particularly in site identification and patient recruitment. AI can address longstanding challenges in clinical research, offering a four-part process to enhance its application in this field. A case study illustrates how AI has facilitated enhanced patient identification, showcasing its benefits in the healthcare industry.California has emerged as a prominent center for biotech innovation, with key hubs in San Francisco, San Diego, and Los Angeles. Despite attracting investors and expanding its footprint, biotech companies in California are implementing layoffs to reduce costs. Joe Panetta, president and CEO of Biocom California, examines the strengths and weaknesses of the life sciences sector in the state. Additionally, the text emphasizes the significance of proactive asset management strategies for pharmaceutical manufacturers in light of upcoming pharma and biotech conferences in 2025.
Oak Street Health, headquartered in Chicago and a wholly-owned subsidiary of CVS Health since 2023, has agreed to pay $60 million to resolve allegations that it violated the False Claims Act by paying kickbacks to third-party insurance agents in exchange for recruiting seniors to Oak Street Health's primary care clinics, according to a news release issued by the U.S. Department of Justice (DOJ). Reporting the lead story during the next live edition of Monitor Mondays will be Max Wollman, a partner in the Washington office of Whistleblower Partners, LLP.The civil settlement includes the resolution of claims brought under the qui tam or whistleblower provisions of the False Claims Act by Joseph Stinson. Under those provisions, a private party can file an action on behalf of the United States and receive a portion of any recovery. Mr. Stinson is expected to receive $9.9 million, according to the DOJ.Other segments during the weekly Internet broadcast will include these instantly recognizable features:•Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.•The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors. •Legislative Update: Adam Brenman, senior government analyst for Zelis, will report on current healthcare legislation.•Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.
Send us a Text Message.Jill Pellegrino is CEO of AutoCruitment ( https://www.autocruitment.com/ ), a company with a focus on identifying, targeting, and qualifying patients for clinical trials with direct-to-patient recruitment, technology, and engagement services and which has to date been involved in randomizing over 12,000 patients into clinical trials across more than 120 conditions for clients including Pharmaceutical, Biotech, and Contract Research Organizations. Jill has over 15 years of leadership experience in patient recruitment, real world evidence and clinical research site operations and is passionate about growing businesses that rely on innovative, data driven methods to reach patients to provide them with opportunities to participate in research opportunities. Most recently Jill was at CVS Health where she was responsible for establishing and growing the Real World Evidence and Patient Recruitment businesses and her businesses were successful in placing 35,000 patients into research opportunities in both clinical trials and research settings, drastically increasing diversity participation in research studies. Prior to CVS Health, Jill was General Manager of Accelerated Enrollment Solutions, which was comprised of 2,000 employees across 11 countries and encompassed a patient recruitment offering and clinical research site network of 160 sites. Jill received her Bachelors degree from LaSalle University in Mathematics and Computer Science. Support the Show.
In this episode of Life Science Success, Ross Jackson, the guy who wrote two books about patient recruitment, is returning to tell us about his new patient recruitment book. Ross is a specialist in patient recruitment for clinical trials, having helped deliver many thousands of patient registrations for clients in the UK, Europe, and the US. The key highlights from the interview: Ross Jackson is a specialist in patient recruitment for clinical trials with experience in the UK, Europe, and the US. He has authored two books on the subject. His career journey began in digital marketing, where he initially recruited patients for a doctor's new treatment. Over time, he shifted his focus to healthcare and clinical trial recruitment. Patient recruitment faces challenges related to awareness and access. Many people are unaware of clinical trials, and misconceptions like being seen as "guinea pigs" persist. Lack of understanding about the importance of clinical research compounds the issue. Ross Jackson's first book focused on using Facebook ads for patient recruitment. It aimed to make it easier for research sites and others to access potential trial participants effectively. His new book takes a unique approach, featuring a fictional character named Josh Black, a puzzle solver who tackles patient recruitment challenges. The book explores various aspects of patient recruitment and aims to make the topic more accessible and engaging. Ross emphasizes the need for collaboration within the industry and the potential impact of AI, particularly natural language processing, in improving patient recruitment processes. He also mentions his excitement about attending a conference and watching his first Super Bowl in Orlando, highlighting his interest in sports and the upcoming event. The interview concludes with gratitude for sharing information about his new book and the hope that it will benefit those interested in patient recruitment. The book is available on Amazon.
Director of Marketing & Patient Engagement Discusses Clinical Research Patient Recruitment
Andrea Chial, co-founder and COO of AlzWell, showcases their innovative AI platform for clinical trial matching which received the 2023 SCRS Site Tank Award. Hear the impact of streamlining site operations and helpful advice for sites interested in AI or technology implementation.
Todd Albin, CEO of Cedar Health Research, discusses the groundbreaking recruitment strategy that earned them the SCRS Site Patient Innovation Recruitment Award (SPRIA). Hear Cedar Health's integration of technology to pre-identify eligible patients in healthcare practices for a challenging study. Albin emphasizes their comprehensive approach to diversity, highlighting the success of engaging diverse communities through a dedicated task force. Explore the synergy between site and industry partnerships and Cedar Health's plans for the future, focusing on optimizing technology, enhancing outreach, and improving diversity initiatives.
Innovating Patient Recruitment: A Conversation with BBK Worldwide Founders Joan F. Bachenheimer and Bonnie A. Brescia The Conference Forum moderates a webcast featuring Joan F. Bachenheimer and Bonnie A. Brescia, the founders of BBK Worldwide, who walk us through the evolution of patient recruitment and engagement, the connection to the women's and consumer healthcare movement, the need for changes in communication and the rise of the patient voice. They also address the impact of scientific advances on patient recruitment and the importance of preparing to meet the evolving changes. The timing of the webcast coincides with the company's 40-year anniversary. Guests: Joan F. Bachenheimer, Founder, Chief Executive Officer, BBK Worldwide Bonnie A. Brescia, Founder, Chief Development Officer, BBK Worldwide Moderated by: Valerie Bowling, Executive Director, Conference Forum For more information on BBK Worldwide, visit www.bbkworldwide.com For more information on the Conference Forum, visit www.theconferenceforum.org
At this year's Diversity Site Solutions Summit, SCRS hosted a variety of breakout discussions covering important topics to enable diversity, equity, inclusion and access in clinical trials. Today we're highlighting some of the takeaways from one of those breakouts, which focused on successful patient recruitment and engagement strategies. Hear from Adrelia Allen from Merck, Deena Bernstein with Datacubed Health, Lacey Clements of IMA Clinical Research and Brittane Strahan from BEKHealth as they share the biggest takeaways and lessons learned from the discussions at the Summit.
In today's episode of Category Visionaries, we speak with Hala Borno, Founder and CEO of Trial Library, an evidence-based platform for improving patient recruitment and diversity in oncology clinical trials, about why a more representative candidate pool is key to the future of better health for everyone. Trial Library partners with study sponsors to recruit candidates from a wide range of backgrounds to make sure that the principles of health equity are built into the process from the bottom up. We also speak about Hala's personal experience with her mother's care choices that led her to a career in medicine, how she balances maintaining a commitment to patients with the responsibilities of being a CEO, what it means to build a public benefit company with empathy as its ‘North star,' and why diversity in clinical trials depends largely on healthcare providers' role as the gatekeepers. Topics Discussed: How her mother's personal challenges with overcoming health barriers led Hala to a career in medicine Hala's background as a researcher in health equity, and what that term means in the context of the modern economy What it's like to found a ‘public benefit company' with empathy as its guiding principle in a highly competitive economy How Trial Library generates income by acting as a recruitment intermediary for study sponsors and helping them meet diversity targets The challenges of keeping a commitment to patient health while also taking on the responsibilities of a startup CEO Why healthcare providers remain the gatekeepers to clinical trials, and what their role in achieving health equity in the future is likely to be Favorite book: The Emperor of All Maladies
Joining us in this episode of Who Would Have Thought is Victoria Donovan, Founder and CEO of Clinically Media, an award-winning full-service agency specializing in patient recruitment and retention in clinical research. Tune in to learn how Clinically Media is reinventing the recruitment and retention process to address the lack of diversity and inclusion in clinical trials.Victoria talks about developing trust and engagement in clinical research for marginalized communities, how the world of digital healthcare can improve disparities in clinical trials, and what's in store for the future of clinical research.Victoria describes the key role of decentralized clinical trials in diversifying patient populations and how we can build more trust between clinical researchers and patients who are reluctant to engage in the healthcare system. Plus, she highlights the immense value of having a diverse group of patient advocates as part of the patient recruitment process.To learn more about Clinically Media, visit: http://www.clinicallymedia.comResources Mentioned:Article: Diversity, Equity, and Inclusion in Patient Recruitment and Retention by Kate Schroeder, Seth Palmer, MBA, CDMP: https://bit.ly/3VX4ubn The Power of Patients: https://www.powerofpatients.com About Our Guest:Sometimes your true calling in life isn't entirely apparent until an opportunity appears right in front of you. For Victoria Donovan, this is partly how she founded Clinically Media in 2017. What started as freelance marketing jobs for pharmaceutical companies and biotech firms, turned into a network of companies needing assistance with larger projects, including the formidable task of recruiting patients for clinical trials. Now, Victoria is the Founder and CEO of Clinically Media, an award-winning full-service agency specializing in patient recruitment and retention in clinical research. Clinically Media helps drug development and device companies efficiently source patients using data-driven, cost-effective solutions, as well as prepare for fundraising and commercial launch. Connect with Victoria on LinkedIn: https://www.linkedin.com/in/victoriadonovan About SmartTab: SmartTab is driving the future of digital medicine by developing a superior patient-centered personalized drug delivery platform in the form of a wireless ingestible capsule. The patient experience fuels SmartTab's commitment to create novel, effective therapies that improve patient outcomes and compliance. For more information visit: https://www.smarttab.co/
When it comes to patient recruitment strategies, there is no one-size-fits-all approach. So how do you raise clinical trial awareness and develop innovative solutions for recruitment that break down silos and improve patient outreach? In this episode, Kelly McKee and Alicia Staley of Medidata are joined by Tricia Barrett, Chief Operating Officer at Praxis & Crowley Webb, to discuss what an efficient direct-to-patient recruitment campaign looks like. Learn how to drive diverse patient recruitment by moving from transactional, traditional strategies to innovative, people-focused approaches. Tricia oversees all Praxis operations from proposal generation through completed, enrolled studies. Her experience encompasses a wide range of therapeutic areas and strategies. Tricia brings a unique approach to patient recruitment that focuses on sound science and innovative execution, while always keeping the patient experience top of mind.
What are decentralized clinical trials? What are the benefits of decentralized clinical trials? Why are decentralized clinical trials the way of the future?Emily Mitchell, Executive Director of ICON's DCT team, discusses the benefits of these trials and what needs to be considered to ensure these benefits are realized. Emily Mitchell has over 15 years of experience working in the CRO industry in Data Management, Project Management, and Clinical Operations. During her tenure at ICON, Emily partnered with an actigraphy vendor to run a pilot study with employees on the wear compliance and comparison of a medical grade activity tracker to a commercial grade version. Before the pandemic, Emily helped set up and support the first fully decentralized trial at ICON. She has continued to present at various conferences around the best practices for decentralized studies, ensuring minimized patient and site burden while optimizing data capture. Emily is an active member of the Society of Clinical Data Management (SCDM) and has presented about decentralized trials at numerous conferences.ICON is the only CRO to offer all services (without the need to contract third-party services or technology) and deliver end-to-end integrated decentralized clinical trial solutions. ICON supported the delivery of the first decentralized clinical trial that has had positive published results in a medical journal – Nature MedicineWe are talking about⭐ Decentralized clinical trials⭐How they benefit patients⭐The impact on budgeting⭐Successful deployment of clinical trials an⭐ Much, much moreYoutube
Clinical Trial Podcast | Conversations with Clinical Research Experts
Phase I trials are generally conducted in healthy participants or in patients with no treatment options such as oncology patients. Unlike late phase trials, Phase I (also known as early phase) studies have different patient recruitment challenges. To learn more, I invited Dr. Graham Wood, Executive Vice President, USA at Nucleus Network. Dr. Wood is a leader in the conduct and design of clinical pharmacology studies having held senior executive roles in a number of the top clinical research sites in the world. In total, he has over 22 years of experience and has been involved with more than 200 first-in-human studies as well as over 2,000 studies across all areas of clinical pharmacology. After finishing his PhD in Neurology and Neurosurgery, Graham worked at MDS Pharma Services, Cetero Research, Manna Research and Altasciences as well as spending two years working at biotechnology companies. * This podcast is brought to you by Slope. Slope provides an online eClinical Supply Chain Management (eCSCM) platform for sponsors and research sites collaborating on complex, sample-intensive, early-stage clinical trials. The Slope eCSCM platform reduces clinical trial risks, reigns in costs, improves the productivity of clinical trial collaborators, and increases subject retention by moving the manual, spreadsheet-driven, and error-prone processes used to manage and track clinical supplies and biological samples to a digital platform. To learn more, visit slope.io and ask to speak with a solutions coordinator today. *
In this episode of the Life Science Success podcast I interviewed Ross Jackson - Literally, The Man Who Wrote the Book on Patient Recruitment for Clinical Trials using Facebook Ads. We discuss everything from SEO to current and future challenges in patient recruitment.
Jackie Kent, Chief Customer Officer at Medidata, a Dassault Systèmes company, shares background on the SCRS Diversity Awareness Program and takeaways from hosting diversity-focused discussions with sites, patients, and industry partners. What strategies are working, and what can we expect next to ensure better diversity in clinical trials? Listen to this episode to learn more and be sure to join us at the inaugural Diversity Site Solutions Summit in Austin, Texas this May! https://diversitysitesolutionssummit.com/
Ross' LinkedIn: https://www.linkedin.com/in/rossjacksonmarketing/Join this channel to get access to perks:https://www.youtube.com/channel/UCvw9kVKHEyAlZPZ6ZuOd2VA/joinText Me: (949) 415-6256My podcast is Random Musings From The Clinical Trials GuruListen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/dp/1090349521/...Text "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe Clinical Research Circle: https://www.youtube.com/channel/UCgOSm8EN_M7xf9Xfw1m778wMy TikTok: DanSfera
How To Improve Patient Recruitment with Matt Walz and Trial Bee Don't forget to Subscribe for new content! Merch: https://teespring.com/stores/elite-clinical-research-merch Subscribe: https://youtube.com/eliteclinicalresearch Email: eliteclinicalgroup@gmail.com Podcast: https://anchor.fm/clinical-research-podcastSteemit: https://steemit.com/@ecrgmediaAdvertise: eliteclinicalgroup@gmail.com Watch: » Industry News: https://goo.gl/fNXpQ5» All Videos: https://goo.gl/87XEFW» Interview Recaps: https://goo.gl/wJsk6W» Glassdoor Reviews: https://goo.gl/AbQzqe We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education ------------------------------------------------------------------------------------------------------------ Elite Clinical Research Group or ECRG for short is a content creating conglomerate that offers many services to individuals in the clinical research and pharmaceutical space. We always keep our "Why" of improving patients lives in mind with everything we do and are always looking to partner with people that are of like mind. Clinical Research is one of the hottest fields in the world right now and thousands of college graduates, masters candidates and phd graduates are looking to enter the clinical research world. Reach out by comment or email if we can help in any way. --- Send in a voice message: https://anchor.fm/clinical-research-podcast/message Support this podcast: https://anchor.fm/clinical-research-podcast/support
Tune in as Steven Geller, PhD, Medical Director at Centennial Medical Group, shows you the patient recruitment strategy that earned the 2021 SCRS Site Patient Recruitment Innovation Award (SPRIA), which celebrates one site that has demonstrated innovation in its patient enrollment. Dr. Geller also shares insights on industry recruitment challenges and how sites can achieve and exceed enrollment goals. Learn more about SPRIA at https://sitesolutionssummit.com/
Yvan's LinkedIn: https://www.linkedin.com/in/yvanlamoureux/Join this channel to get access to perks: https://www.youtube.com/channel/UCvw9kVKHEyAlZPZ6ZuOd2VA/join Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK! https://www.amazon.com/dp/1090349521/... Text "guru" to 855-942-5288 to join VIP list! My blog: http://www.TheClinicalTrialsGuru.com My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy: http://www.TheCRCacademy.com Latinos In Clinical Research: http://www.LatinosinClinicalResearch.com The Clinical Research Circle: https://www.youtube.com/channel/UCgOSm8EN_M7xf9Xfw1m778w My TikTok: DanSfera
Patient recruitment is still the crux of any successful clinical trial. In this series, we get tips, tricks and feedback from members of the clinical research community who are actively involved in patient recruitment efforts. In this episode we have Christine Narro, who discusses the importance of recruitment and it's downstream effects, Ashley Heard who provides some insight to help increase subject diversity and Dr Christopher Gantz who discusses tips for developing a centralized recruitment program at the site level.
http://www.latinosinclinicalresearch.com
In this episode, Sarah talked about attending the Alzheimer's Association International Conference (AAIC) 2021 virtually this year and discussed increasing diversity in Alzheimer's clinical trials as an important topic that was part of the conference. Black and Hispanic people are more likely to be diagnosed with Alzheimer's compared to Caucasians. Sarah outlined the results of some studies shared at the meeting, including a study that revealed people of minority backgrounds would be more likely to participate in a trial if they were directly invited to participate by someone of their own race, and if a family member had the disease. Exclusion criteria could also inadvertently exclude potential participants based on race, warranting the need for trial designs that foster greater inclusivity, including outreach tools, to broaden recruitment.Related to the theme of racial inequities in healthcare as well as the health and beauty industry, Ayesha discussed a recent lawsuit launched against Johnson & Johnson over its iconic baby powder by a Black women's advocacy group. The group claims that the company engaged in targeted marketing of their baby powder to Black and Hispanic women, whilst knowing for decades about asbestos impurities in their product; the company has been facing thousands of individual lawsuits over the years over links to use of the baby powder and ovarian cancer and mesothelioma. As part of the lawsuit, the advocacy group is calling on Johnson & Johnson to rectify its past ad campaigns by creating new adverts that are equitable and have “corrective marketing” that warn Black women of the risks associated with the product.Read the full articles here: Diversity in Clinical Trials: Tackling the Issues in Alzheimer's Research at AAIC 2021Black Women's Group Launches Lawsuit Against Johnson & Johnson Over Targeted Baby Powder AdsFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
Clinical Trial Podcast | Conversations with Clinical Research Experts
This podcast episode highlights the top reasons for patient recruitment failure in clinical trials from an investigator perspective. The podcast episode will help you understand how Sponsor and CRO personnel including software vendors can best support investigators meet or exceed their patient recruitment. The goal is to bring more awareness on how to prevent patient recruitment failure and complete enrollment as planned. Initial funding insufficient to reimburse recruiting staff/sites Context-specific logistic obstacles (e.g., urgent transfers from intensive care, different treatment availabilities at different centers or on weekends) Lack of methodological/logistical support (e.g., from contract research organization or clinical trial unit) Prejudice against effectiveness of trial interventions New evidence from other study about effectiveness of trial interventions Administrative burden/time constraints Lack of eligible participants - Overestimated prevalence (mostly reported as overly narrow eligibility criteria) Concurrent competing trials High burden (e.g., many visits, invasive procedure, questionnaires, costs) To learn more and get detailed show notes, visit clinicaltrialpodcast.com Podcast Sponsor: This episode is brought to you by Florence Healthcare.
Seth Rotberg, Patient Recruitment Manager at WEGO Health & Co-Founder of Our Odyssey, shares his views on how to empower rare disease patients, improve clinical trials, and move towards a truly patient-centric practice. He also discusses how and why Pharma should leverage social media and patient “influencers” to reach more patients.Schedule a meeting with Natalie Yeadon: https://www.meetwithnatalie.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/ImpetusadboardsImpetus YouTube: https://www.youtube.com/ImpetushealthcareSeth Rotberg: https://www.linkedin.com/in/sethrotberg/WEGO Health: https://www.wegohealth.com/Our Odyssey: http://www.ourodyssey.org/
Tell us a little bit about yourself and 1nHealth.I’m kind of a cross between a life science veteran and an e-commerce veteran. I created 1nHealth based on those philosophies to answer the question, “how do you use compelling marketing to incite individuals to take action?” At 1nHealth, we are putting an advertising catalyst in front of individuals in hopes of getting them to enroll in clinical trials. Early last year, the COVID-19 pandemic was beginning to impact sponsors' ability to run clinical trials. What kinds of choices did you see them making?For the first stage, sponsors’ and CROs initial decision was to wait. The evening the NBA cancelled the season was kind of the stark flag in the sand that this year was going to be very different. After that, sponsors and CROs had to adapt and create a more robust strategy to recruit participants, thinking beyond the standard playbook of bringing participants into sites.We saw sponsors choose to go the virtual route. Did we start to see that in the patient recruitment space as well? How are patient recruitment vendors adapting to this shift to more decentralized trials?You can take the same protocol and apply a digital lense to it to get the same results. Overall, what we have seen is instead of looking at sites as the bread and butter for patient recruitment, we are seeing studies and RFPs come to us with digital as the central point to recruitment with sites as the adjunct for recruitment. How was 1nHealth able to effectively reach people throughout the pandemic? What every digital recruitment firm is going to do is put ads in front of people and hope they take some action. Here at 1nHealth, we believe that marketing around clinical trials is about starting a conversation. We are able to reach folks for clinical trials because they are what is outside the “norm” for clinical trial recruitment. Second, we are using creative content that belongs on their newsfeed or search bar. The clinical research industry has been accused of being slow to adopt AI compared to other industries. For sponsors who have found themselves turning to digital solutions in response to COVID, what advice would you give them? How should they adjust their patient recruitment strategies?The status quo does need some shaking up. In many cases sponsors are used to sticking to what is required of the participants. We want to get sponsors to think about what is going to get people to read more - it has to be about the patient when we think about what patient centricity online looks like. We want to create content that is native to the environment and gets them to take the next step. What do you think the state of patient recruitment will be after COVID-19? Do you think it will be predominantly digital or will site-based trials come back?I think it’s going to be somewhere in the middle. COVID forced us to stay in our houses for a while, and as that lifts we’ll see the requirement for sites to be part of studies still remains. I think there is a seismic shift that is happening in the push for decentralized trials. With all of that in mind, digital will become more central to trials as some trials cannot function without sites. Are there any final thoughts you would like to share with our audience?I just want to reinforce how we have an industry that is so sophisticated and technical. We need to remember that these are people who are scrolling through their feed and come across a trial ad. Sponsors need to work to throw out sterile advertising copy because the way we talk to them is what compels them to move forward in the study.
Claudia Christian of FHI Clinical discusses Covid-19 impact on Clinical Trials. The challenge of patient recruitment in Clinical Trials Claudia Christian is the Senior Vice President, Clinical Operations of FHI Clinical. FHI Clinical has, among other things provided clinical operations services for ACTT-1 trial of remdesivir for treatment of COVID-19. Claudia Christian has held positions in pharmaceutical, biotech and CROs across multiple indications. Since 2014, she has devoted her expertise full-time to infectious disease research, including managing multiple study protocols and developing sites in support of outbreak responses. https://www.fhiclinical.com/the-elusive-covid-19-patient-subject-recruitment-remains-challenging-despite-increasing-case-numbers/
In this PharmaTalk podcast, Kelly McKee of Medidata leads a multi-perspective panel discussion on the challenges and opportunities of adopting a decentralized model for clinical trials and ensuring clinical trial continuity with live video visits. Together they discuss lessons learned from the rapid adoption of technologies to allow for more decentralized trials, how incorporating multiple perspectives highlights areas of growth when utilizing a decentralized approach, and the possibility of hybrid trials becoming the new normal for the near future. Host: Kelly McKee is the Senior Director of Patient Recruitment and Registries at Medidata Guests: Anne Marie Mercurio is a patient and research advocate and caregiver. Rosamund Round is Vice President of PAREXEL’s Patient Innovation Center. Jeff Kingsley, DO, is the founder and CEO of IACT Health. For more information about PharmaTalk podcasts, visit theconferenceforum.org. A special thanks to the team at Medidata for their support in presenting this podcast.
Clinical Trial Podcast | Conversations with Clinical Research Experts
I’m always excited to speak with software entrepreneurs in clinical research and this episode is no excpetion. Our guest on today’s show is Maya Zlatanova, CEO of FindMeCure. Maya and her team are creating a “google” for clinical trials. She is on a mission to make it easy for patients to find ongoing clinical trials She wants to solve patient recruitment challenges enabling patients and doctors to connect with each other She believes in the power of stories, not just facts, something unheard of (but much needed) in clinical research. FindMeCure is dedicated to simplifying the patients' journey while volunteering for a clinical trial while helping the industry plan their trials with the full picture of country capacity, sites' experience and patients needs and journey. Maya is a healthtech entrepreneur, clinical research expert, and pharma industry speaker with over 15 years of global experience in clinical research regulations, patient recruitment, and engagement, clinical trial feasibility, and operations. Maya’s strongest skill is empathy. Her principles in life are to be trustworthy, care for other people and give first. She also cherishes her never-ending curiosity about how life and the universe work, how to improve ourselves and our environment. Please join me in welcoming Maya Zlatanova on the Clinical Trial Podcast. [2:25] About Maya’s company FindMeCure, Maya’s experience working on clinical research software for the British government and first online GCP training [4:14] Maya’s sister was diagnosed with an eating disorder and struggled to find treatment. This let to Maya looking at clinical trials from a patient perspective [6:06] Creating a global platform for patients to find out about alternative treatments in clinical trial setting [8:29] Connecting patients in one country with clinical trials in another country [9:55] Challenges for patients include: Human factors such as need to be close to family Traveling long distances to participate in clinical trials Being treated by different doctor (trial investigator) than their primary physician [13:01] Patient recruitment process can benefit from change. Currently we first select sites and then bring patients into these sites [14:26] We need to break things to innovate [15:25] In an ideal world, we would have a centralized electronic health record, we know where patients are, patients are monitored with telehealth solutions, central site that is leading other sites [16:55] Everyone wants to go to the experienced sites [19:43] Hybrid clinical trials [20:28] Need to support sites and investigators by questioning what sites should and shouldn’t do [24:05] convincing decision makers to select sites in other geographies using financial metrics [28:03] Language is not an obstacle at most sites. Ethical considerations can pose an issue. CRO with local office Site Management Organization (SMO) Own CRA networks [32:00] Adoption of technology in clinical research such as sites being open to new remote solutions [33:35] Whatever works for clinical research will work for the healthcare sector [34:03] ACRES helping sites getting accredited and certified if they follow certain standards for clinical trials [36:32] GCP is the only standard in clinical research. For example, it is not sufficient for patient centric trials [38:02] Need to align on initiatives such as patient engagement guidelines in EU and USA [39:45] Empathy is a feeling for people and imagining yourself in their shoes. Being open to the fact that you could be wrong. Listening to people, hearing you are wrong, and converting to the right thing [42:42] Maya’s secret weapon is speaking with different people with different backgrounds to learn and grow Resources mentioned: Society of Clinical Research Sites (SCRS) Association of Clinical Research Professionals (ACRP) Food and Drug Administration (FDA) Alliance for Clinical Research Excellence and Safety (ACRES) TransCelerate - Pharmaceutical Research and Development Pharmaceuticals and Medical Devices Agency (PMDA) EUPATI: Patient Engagement Through Education - EUPATI
Pharmaceutical executive Peter A. DiBiaso, MHA, a triathlete who has successfully completed the grueling Ironman, learned at age 49 he had early-onset Parkinson’s disease. He shares his experiences—and triumphs—in this episode.What started as a small tremor in his right hand and a stiffness in his right ankle ended up changing his life. It was a blow, but he knew what to do: The diagnosis brought his personal and professional life full circle. Five years later, he reports minimal disease progression. He is doing well and remains incredibly active. Other than well-managed medication, to what does he attribute his success so far?Staying fit and continuing to be an athlete. He is still running marathons and recently scaled Mount Kilimanjaro, the highest mountain in Africa.Engaging with patient advocacy groups—in particular, the Michael J. Fox Foundation. (In fact, his Kilimanjaro trek was part of a Team Fox effort to raise money for the foundation.)His ability to navigate the system. He has also been involved in six clinical trials—both interventional and observational. He knew the value as an industry insider. Now, he appreciates the value from the patient perspective—and he better understands the frustrations patients face. It too often falls on the patients to initiate discussions about clinical trials. That’s fine for him, he says, but what about those who don’t know trials are available?His professional life has focused on patient recruitment issues, so he brings a 360-degree perspective. Sponsors, he says, need to focus on more than the academic and clinical elements; they must address real-world issues and trial participants’ challenges—even those that seem minor, like parking.It comes down to patient-centricity, he explains—putting patients at the center of the clinical research enterprise. It is becoming more common, but there’s still a long way to go.Peter DiBiaso, MHA, is a consultant to drug development companies and has worked at Pfizer, Shire, Vertex, and IQVIA. He is married and has two children, and he and his family split their time between Paris and Boston.
Jeslyn's LinkedIn: https://www.linkedin.com/in/jeslynatanu/ Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK! https://www.amazon.com/dp/1090349521/... Text "guru" to 31996 to join VIP list! My blog: http://www.TheClinicalTrialsGuru.com My business Patreon Page: http://www.patreon.com/dansfera My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy: http://www.thecrcacademy.com
Join our daily quarantine meetup: https://www.anymeeting.com/785-991-750 Text me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru GET THE BOOK! https://www.amazon.com/dp/1090349521/... Text "guru" to 31996 to join VIP list! My blog: http://www.TheClinicalTrialsGuru.com My business Patreon Page: http://www.patreon.com/dansfera Site Owner Academy: http://www.theclinicaltrialsguru.com/... My CRO: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy: http://www.thecrcacademy.com
Deep Lens: https://www.deeplens.ai/ Text me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru GET THE BOOK! https://www.amazon.com/dp/1090349521/... Text "guru" to 31996 to join VIP list! My blog: http://www.TheClinicalTrialsGuru.com My business Patreon Page: http://www.patreon.com/dansfera Site Owner Academy: http://www.theclinicaltrialsguru.com/... My CRO: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy: http://www.thecrcacademy.com
Zachary's email: info@leapcure.com Text me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru GET THE BOOK! https://www.amazon.com/dp/1090349521/... Text "guru" to 31996 to join VIP list! My blog: http://www.TheClinicalTrialsGuru.com My business Patreon Page: http://www.patreon.com/dansfera Site Owner Academy: http://www.theclinicaltrialsguru.com/... My CRO: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy: http://www.thecrcacademy.com
On the fourth episode of the Personalized Medicine Podcast we switch gears from biomarker research to clinical trials with Christian Erb. Christian is a co-founder and CEO of Mondosano, a Hamburg-based company that addresses the bottleneck for a successful clinical trial – patient recruitment. Listen to our discussion with Christian to learn more about:◦ The story behind the founding of Mondosano ◦ Why clinical trials do not have good reputation among patients◦ Why patient education is the key to improve patient recruitment◦ Patient journey to and through a clinical trial ◦ How Mondosano helps pharma companies and study sites to recruit patients◦ Why most clinical trials fail to finish on time◦ Patient stratification on clinical trials◦ How to prevent patient drop-out◦ Preserving data privacy while recruiting patients and managing trials◦ Three most anticipated developments in the clinical trials space ◦ A way forward for personalized medicineGet in touch with Christian:◦ Twitter: @NTpreneur◦ LinkedIn: Christian Erb◦ Email: christian.erb@mondosano.de◦ Web (Mondosano, German website): https://www.mondosano.de/◦ Web (Mondosano, international website): https://www.mondosano.org/Make sure to download the full show notes with our guest's bio, links to their most notable work and our recommendations for further reads on the topic of the episode at personalizedmedicinemedia.com
This 5 minute podcast summary helps prepare listeners on what they can expect at the4th Annual Patients as Partners Europe event, taking place January 27th and 28th in London. The venue is the Millennium Gloucester Hotel. In a nutshell, Patient as Partners is the first conference in Europe dedicated to understanding how working with patients can drive greater clinical trial efficiencies throughout the entire medicines development process. It is ultimately about how to reduce risk in the development of hugely, costly clinical trials through working with patients. It is a wonderful opportunity for pharma and biotech and patient disease advocacy groups to come together and learn from each other. The 2020 Summit is chaired by Claire Nolan, of Charities Research Involvement Group, GSK’s Andrew Garvey and Parexel’s Rosamund Round. Our patient keynote guest is Lesley Gosden. Lesley is a Parkinson’s patient and advocate who participated in the GDNF clinical trial, which was featured on the BBC. For more information, visit the conferenceforum.org.
Donations (You never know what may happen) Venmo: @Dan-SferaGET THE BOOK! https://www.amazon.com/dp/1090349521/ref=mp_s_a_1_2?crid=C7PR8LO0E2FC&keywords=the+comprehensive+guide+to+clinical+research&qid=1555945352&s=gateway&sprefix=the+comprehensive+guide+to+clinica&sr=8-2Text "guru" to 31996 to join VIP list!http://www.TheClinicalTrialsGuru.comSite Owner Academy: http://www.theclinicaltrialsguru.com/site-owner-academy/My CRO: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comThe CRC Academy: http://www.thecrcacademy.com
Introduction [00:42]Learn about best practices for patient recruitment, one of the biggest concerns in the clinical trial industry. We’ll discuss the importance of precision recruitment and site-follow up, as well as patient recruitment challenges like diagnosis, eligibility and diversity.What’s the number one problem with clinical trials? [03:03]The number one problem with clinical trials is speed. Research isn’t happening as quickly as it should, and patients are waiting too long for new and better treatments while sponsors are spending too much money and time. The most effective way to address this problem is smart and efficient patient recruitment strategies.What’s the importance of patient recruitment? [03:45]There’s a gap between what patients need and the ability of clinical research to address these needs. About 80% of clinical trials are delayed or stopped due to enrollment issues, meaning that the drugs take longer to get to market or they never get there at all. Some disease prognoses are shorter than the average amount of time it takes for new drugs to get to market, which is 10 years. These patient stories illustrate the necessities of fixing the issues with patient recruitment from the patient side..Why does this gap exist? What are some factors that make a study difficult to recruit patients? [04:40]There are a number of different factors, such as complex protocols with increased eligibility criteria, making trials harder to recruit for. Additionally, there’s a lack of patient awareness around clinical trials. They don’t hear about trials because doctors rarely bring them up, or they have the misconception that trials are only for people with no other options. Education about clinical trials is crucial to improving patient recruitment efforts.How do complex protocols effect patient enrollment? Are these trial design problems, or just ones that require a specific approach to recruitment? [06:06]The increased complexity of protocols mirrors the increased complexity in the science of the drugs being tested. As medications become more targeted, especially in therapeutic areas like oncology, it has become more difficult to find patients who can participate in clinical trials. Precision recruitment techniques, with very targeted patient outreach, are more effective at finding patients who meet specific trial criteria.How has the role of the patient changed in the recruitment landscape? [08:31]Patients are becoming their own advocates by doing research on their dignoses, joining patient communities, and actively looking for treatment options. When running patient recruitment, it’s important to understand the voice of the patient to communicate and engage with them where they’ll be most receptive.How can other clinical trial stakeholders reduce site burden through patient recruitment? [09:42]In the future, the ability to measure various aspects of airway function will improve due to the shift towards personalized medicine, with new methods regulated and approved by the FDA.What might sponsors be surprised to learn about digital patient recruitment technology in clinical trials? [11:39]There’s been a slow adoption process for digital patient recruitment technologies, mostly due to the changes it can require to a sponsor’s internal processes. The industry is still relying on traditional advertising tactics for recruitment, but the digital world has untapped potential. Almost everyone is online or using a smartphone, including the aging population which is more tech savvy than it ever has been before.How can patient recruitment address the issue of diversity in clinical trials? [14:50]In June 2019, the FDA issued draft guidance on the importance of increasing diversity in clinical trial populations. It’s often incorrectly thought that communities of color are not interested in taking part in medical research. However, research teams and recruitment companies need to cater their outreach in a way that contextualizes clinical trial opportunities, addresses historical concerns, and gives people the information they need to feel confident about volunteering for clinical research.The patient recruitment market is expected to continue to grow into 2020. Where is it headed and how will it continue to evolve clinical trials? [18:10]Increased patient awareness about their health decisions and data will shape and impact many industries, including patient recruitment.
Donations (You never know what may happen) Venmo: @Dan-SferaGET THE BOOK! https://www.amazon.com/dp/1090349521/ref=mp_s_a_1_2?crid=C7PR8LO0E2FC&keywords=the+comprehensive+guide+to+clinical+research&qid=1555945352&s=gateway&sprefix=the+comprehensive+guide+to+clinica&sr=8-2Text "guru" to 31996 to join VIP list!http://www.TheClinicalTrialsGuru.comSite Owner Academy: http://www.theclinicaltrialsguru.com/site-owner-academy/My CRO: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comThe CRC Academy: http://www.thecrcacademy.com
Today we are going to interview Felicia Irvin, Director of Sales and Marketing for IACT Health, a multi-specialty research site. She has about a decade of experience in finding patients for research trials. She talks to Dr. Kingsley about recruitment methods and strategies.
Despite advances in science and technology, we still see that 80% of clinical trials are running behind on their enrollment timeline.Mark Summers, Founder of WCG ThreeWire, and President of Patient Engagement at WCG, shares his insights on the current industry model of patient recruitment and the philosophy behind the new patient recruitment paradigm. Things you will learn in this podcast:Shortcomings of the current industry model of patient recruitmentHow to better plan for and deploy patient recruitment strategiesHow to find the most reliable and resource effective patientsThe economic philosophy of planning and deploying a patient recruitment program
Text "guru" to 31996 to join VIP list!http://www.TheClinicalTrialsGuru.comSite Owner Academy: http://www.theclinicaltrialsguru.com/site-owner-academy/My CRO: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy Research News Site: http://www.TheClinicalScoop.comCall/Text: (949) 415-6256Follow Me On:SnapChat: username is dansferaInstagram: https://instagram.com/dansferaTwitter: https://twitter.com/TheRealDanSferaFacebook: https://www.facebook.com/dansferaLinkedIn: https://www.linkedin.com/profile/view...My iTunes Podcast: https://itunes.apple.com/us/podcast/random-musings-from-the-clinical-trials-guru/id1245751329My Stitcher Podcast: http://www.stitcher.com/podcast/dan-s...Google Play Podcast: https://playmusic.app.goo.gl/?ibi=com.google.PlayMusic&isi=691797987&ius=googleplaymusic&link=https://play.google.com/music/m/Ikoltbj2pxcbscwwajoixxdhix4?t%3DRandom_Musings_From_The_Clinical_Trials_Guru%26pcampaignid%3DMKT-na-all-co-pr-mu-pod-16
Today we are going to interview Felicia Irvin, who is Director of Sales and Marketing for IACT Health, a multi-specialty research site. She has about a decade of experience in finding patients for research trials. She talks to Dr. Kingsley about recruitment methods and strategies.
Clinical Trial Podcast | Conversations with Clinical Research Experts
In this episode we discuss how texting patients can dramatically improve the patient recruitment and retention process in clinical trials. When discussing with sites their patient recruiting strategies, i have seen a remarkable spike in the amount of patients that respond and actually have conversations about the trial from texting them instead of calling and emailing. The idea is to meet the patients where they are, if they are more responsive via texting we as researchers go there. #patientrecruitment #ECRG#clinicaltrials Don't forget to Subscribe for new content! Subscribe: https://youtube.com/eliteclinicalrese... Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: https://anchor.fm/clinical-research-p... Steemit: https://steemit.com/@ecrgmedia Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: https://goo.gl/fNXpQ5 » All Videos: https://goo.gl/87XEFW » Interview Recaps: https://goo.gl/wJsk6W » Glassdoor Reviews: https://goo.gl/AbQzqe We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education --- Send in a voice message: https://anchor.fm/clinical-research-podcast/message Support this podcast: https://anchor.fm/clinical-research-podcast/support
http://www.TheClinicalTrialsGuru.comSite Owner Academy: http://www.theclinicaltrialsguru.com/site-owner-academy/My CRO: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy Research News Site: http://www.TheClinicalScoop.comCall/Text: (949) 415-6256Follow Me On:SnapChat: username is dansferaInstagram: https://instagram.com/dansferaTwitter: https://twitter.com/TheRealDanSferaFacebook: https://www.facebook.com/dansferaLinkedIn: https://www.linkedin.com/profile/view...My iTunes Podcast: https://itunes.apple.com/us/podcast/random-musings-from-the-clinical-trials-guru/id1245751329My Stitcher Podcast: http://www.stitcher.com/podcast/dan-s...Google Play Podcast: https://playmusic.app.goo.gl/?ibi=com.google.PlayMusic&isi=691797987&ius=googleplaymusic&link=https://play.google.com/music/m/Ikoltbj2pxcbscwwajoixxdhix4?t%3DRandom_Musings_From_The_Clinical_Trials_Guru%26pcampaignid%3DMKT-na-all-co-pr-mu-pod-16
Clinical research is always delayed. Why? Patient recruitment is cited as the reason across the industry. This partly happens because the efforts put forth by Sponsors & CROs are often put together with less than ideal effort and forethought. Many people in charge of trials are often occupied with the millions of other duties that come with conducting a study. Here are the top 3 failures in digital patient recruitment we have seen from our years in patient recruitment:
My 2019 Conference: https://www.kickstarter.com/projects/2084466163/the-most-practical-clinical-research-conference-ev?ref=created_projectshttp://www.TheClinicalTrialsGuru.comSite Owner Academy: http://www.theclinicaltrialsguru.com/site-owner-academy/My CRO: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy Research News Site: http://www.TheClinicalScoop.comCall/Text: (949) 415-6256Follow Me On:SnapChat: username is dansferaInstagram: https://instagram.com/dansferaTwitter: https://twitter.com/TheRealDanSferaFacebook: https://www.facebook.com/dansferaLinkedIn: https://www.linkedin.com/profile/view...My iTunes Podcast: https://itunes.apple.com/us/podcast/random-musings-from-the-clinical-trials-guru/id1245751329My Stitcher Podcast: http://www.stitcher.com/podcast/dan-s...Google Play Podcast: https://playmusic.app.goo.gl/?ibi=com.google.PlayMusic&isi=691797987&ius=googleplaymusic&link=https://play.google.com/music/m/Ikoltbj2pxcbscwwajoixxdhix4?t%3DRandom_Musings_From_The_Clinical_Trials_Guru%26pcampaignid%3DMKT-na-all-co-pr-mu-pod-16
My 2019 Conference: https://www.kickstarter.com/projects/2084466163/the-most-practical-clinical-research-conference-ev?ref=created_projectshttp://www.TheClinicalTrialsGuru.comSite Owner Academy: http://www.theclinicaltrialsguru.com/site-owner-academy/My CRO: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy Research News Site: http://www.TheClinicalScoop.comCall/Text: (949) 415-6256Follow Me On:SnapChat: username is dansferaInstagram: https://instagram.com/dansferaTwitter: https://twitter.com/TheRealDanSferaFacebook: https://www.facebook.com/dansferaLinkedIn: https://www.linkedin.com/profile/view...My iTunes Podcast: https://itunes.apple.com/us/podcast/random-musings-from-the-clinical-trials-guru/id1245751329My Stitcher Podcast: http://www.stitcher.com/podcast/dan-s...Google Play Podcast: https://playmusic.app.goo.gl/?ibi=com.google.PlayMusic&isi=691797987&ius=googleplaymusic&link=https://play.google.com/music/m/Ikoltbj2pxcbscwwajoixxdhix4?t%3DRandom_Musings_From_The_Clinical_Trials_Guru%26pcampaignid%3DMKT-na-all-co-pr-mu-pod-16
Clinical Trial Podcast | Conversations with Clinical Research Experts
In this episode, I share with you strategies and tactical advice on patient recruitment. Patient recruitment is the foundation of any clinical study. If your trial doesn’t enroll the minimum number of patients required per protocol, you or your company cannot get the data you need to prove your trial hypothesis, determine product safety and effectiveness. More importantly, you cannot bring the medical product to the market on time (or possibly never!). This means loss of revenue and profits for the sponsor but more importantly, the patients that need your therapy won’t get it. In this podcast, I’m going to share with you 4 amazing strategies that will help you with patient recruitment. If you’re directly involved in a clinical study as a sponsor, CRO or even a site, this episode is a must-listen. If you’re creating a product or service for clinical research professionals, you need to ensure your work ultimately supports patient recruitment. Hope you enjoy listening to this solo episode by yours truly. This episode is brought to you by CBI Events. The team at CBI has put together a Digital Therapeutics event in New York City on December 3-4, 2018. Topics range from strategies for new digital health projects to perspectives from the venture capital community on investment requirements for digital therapeutics. Whether you’re a pioneer in this space or want to know just the right amount of information to get started, this event is going to value packed for you. Some benefits from your participation in this event include: Learning strategies on how to ensure data integrity Understanding regulatory approaches to digital therapeutics and how to seamless approval in all regions Finding out about payer approval requirements and uncovering changing business models Collaborating with others on standard definitions and approaches to what constitutes a digital therapeutic And much, much, more. If you want to learn and network with others in the Digital Therapeutics space, you should attend the 2018 event in New York City on December 3-4, 2018. As a listener to this podcast, I’ve got an exclusive $500 discount to this event. When I mean exclusive, it really is exclusive. So head over to http://www.cbinet.com/digitaltherapeutics and use the code CTP500 at check-out to get your $500 discount. Register today to get your exclusive $500 off your event ticket using the code CTP500. This offer is only available to the Clinical Trial Podcast listeners.
In this episode, we cover how you can improve your patient recruitment material to obtain the most amount of patients possible. We will go over how to obtain high-quality images and quick fixes to your patient improvement materials. We will go over a framework that will help you create the best patient with commitment real every time.
http://www.TheClinicalTrialsGuru.comSite Owner Academy: http://www.theclinicaltrialsguru.com/site-owner-academy/My CRO: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy Research News Site: http://www.TheClinicalScoop.comCall/Text: (949) 415-6256Follow Me On:SnapChat: username is dansferaInstagram: https://instagram.com/dansferaTwitter: https://twitter.com/TheRealDanSferaFacebook: https://www.facebook.com/dansferaLinkedIn: https://www.linkedin.com/profile/view...My iTunes Podcast: https://itunes.apple.com/us/podcast/random-musings-from-the-clinical-trials-guru/id1245751329My Stitcher Podcast: http://www.stitcher.com/podcast/dan-s...Google Play Podcast: https://playmusic.app.goo.gl/?ibi=com.google.PlayMusic&isi=691797987&ius=googleplaymusic&link=https://play.google.com/music/m/Ikoltbj2pxcbscwwajoixxdhix4?t%3DRandom_Musings_From_The_Clinical_Trials_Guru%26pcampaignid%3DMKT-na-all-co-pr-mu-pod-16
The 2nd annual Patients as Partners EU is the only conference in Europe that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. In this short podcast, Valerie Bowling, executive director at the Conference Forum gives a brief summary of what to expect at this conference and runs through the highlights. Chairs: Tony Hoos, MD, PhD, MBA Head of Medical, Amgen Europe Andrew Garvey Global Patient Advocacy Lead, GlaxoSmithKline The premier event was attended by roughly 150 people and the program brings back: Accreditation by Patients Included “Ask the Patient” program to give attendees the opportunity to meet a group of individuals who’ve experienced a clinical trial.Attendee “Tool-Box” and an assortment of specially designed materials to help capture ideas. Patients as Partners EU is co-produced with industry, patient advocacy and government to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement across the entire clinical development continuum with the goal of driving greater efficienices. It is attended primarily by pharmaceutical operation and advocacy executives and patient advocacy trusts. There is a small exhibit room with tons of networking. January 23-24, 2018 Radisson Blu Portman Hotel, London, UK For more information visit www.theconferenceforum.org Special rates for trusts and use code TEML for 10% off.
Facilitating Clinical Trials Since we started Health Connect South Radio we have featured several research organizations who are doing research to uncover solutions to several illnesses such as Ebola, HIV, mitochondral diseases, diabetes, and others. This week we featured two companies who are facilitating clinical trials through their respective solutions. Bethany Bray, CEO of AutoCruitment […] The post Facilitating Clinical Trials appeared first on Business RadioX ®.
Donald Jones, Chief Digital Officer, Scripps Translational Science Institute talks with host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer on what's happening with digital in drug development. Don discusses his thoughts on the evolution of new products with digital and the “digitazation” of tools for clinical trials. He also shares his thoughts on the biggest disruptors in pharma. Don and Craig will be featured in an interview as well at DPharm: Disruptive Innovations to Advance Clinical Trials on September 11, 2014 in Boston. Host Craig Lipset Head of Clinical Innovation, R&D Pfizer Guest Donald Jones Chief Digital Officer Scripps Translational Science Institute & Founder & Chairman, Wireless Life Sciences Alliance Producer Valerie Bowling Executive Director The Conference Forum
How a patient experiences a clinical trial is changing. Access, ease, efficiencey, safety and better quality data collection are the target goals. This episode features some of the emerging technologies together with a discussion on the opportunities and challenges to include patient access, recruitment and retention. Predictions for 2014 are shared by our guests. Host: Craig H. Lipset, MBA Head of Clinical Innovation, Worldwide Research and Development, Pfizer Inc. Guests: Tomasz Sablinski, MD, PhD Founder & CEO, Transparency Life Sciences Komathi Stem Senior Director, Product Development, Innovation Lead, Genentech, A Member of the Roche Group, United States
Join guests Kerri Weingard, ANP, COO, Verified Clinical Trials and Susan Salgado, PhD, Founder, Hospitality Quotient as they identify the barriers and limitations in engaging patients in clinical trials. What we can do about it through communication and service? Hosted by Valerie Bowling, Executive Director, the Conference Forum, this episode addresses one of the hottest topics at the Patients as Partners event scheduled for March 3-4, 2014 in Philadelphia. For more information, visit www.theconferenceforum.org About our Guests: Susan Reilly Salgado, PhD founded Hospitality Quotient with Danny Meyer in 2010. Hospitality Quotient offers customized advice and training to inspire, build and sustain a company culture of service in organizations across industries. In addition to her PhD, Susan holds a BS and an MBA from Lehigh University. Susan has also served as an instructor in organizational behavior and business strategy at NYU and as a guest lecturer at Lehigh. Kerri Weingard is the chief operating officer at Verified Clinical Trials (VCT), a New York-based firm specializing in ensuring the integrity of medical studies and clinical trials by creating a database of research study participants trials. Ms. Weingard, who is a nurse practitioner, holds a master’s degree in science from Stony Brook University. She has conducted over 500 clinical trials as a research coordinator and sub-investigator.
Companies outsourcing patient recruitment in emerging markets should have more people on the ground, according to Cutting Edge Information's Shaylyn Pike.
Companies looking to outsource patient recruitment need to think outside the box, says Cutting Edge Information’s director of research Eric Bolesh.
Companies looking to outsource patient recruitment need to think outside the box, says Cutting Edge Information’s director of research Eric Bolesh.
Outsourcing should play a vital role in any patient recruitment strategy, says Cutting Edge Information’s director of research Eric Bolesh.
Outsourcing should play a vital role in any patient recruitment strategy, says Cutting Edge Information’s director of research Eric Bolesh.
An evidence-based approach to planning during protocol development is key to successful patient recruitment according to Joseph Kim, director of clinical operations at Shire Pharmaceuticals.
CRO and Pharma patient recruitment efforts can benefit from social networks and online patient groups, but clarification from the US FDA is still needed.
CRO and Pharma patient recruitment efforts can benefit from social networks and online patient groups, but clarification from the US FDA is still needed.
Date Posted: 03/18/2010Size: 5.77MBLength: 00:12:36Thought Leader: Scott Connor, VP of Marketing, AcurianIn this episode, Mr. Connor describes how social networking can be used as a powerful business tool for patient recruitment for clinical trials.Play PodcastDownload Whitepaper For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Date Posted: 05/17/2010Size: 4.1MBLength: 00:8:58Thought Leader: Roger Smith, Senior VP, Operations, Acurian Inc.In this episode, Mr. Smith provides detailed information related to security standards in patient recruitment, what clinical teams need to consider when selecting the right recruitment partner, and how to navigate and understand the complex guidelines and regulations in this space.Play PodcastDownload WhitepaperFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Date Posted: 12/01/2009 Size: 14.4MB Length: 00:14:04 Thought Leader: Richard Malcolm Ph.D., CEO, AcurianDr. Malcolm talks about risk sharing and performance-based pricing as a way for sponsors to get the best results for their patient recruiting budget.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Date: 09/01/2009Length: 00:22:47Size: 10.4MBThought Leader: Richard Malcolm Ph.D., CEO, AcurianDr. Malcolm talks about planning and measuring return on investment in patient recruitment today, as well as what the future holds in this area.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
© 2020-2025 Ivy Podcast Discovery LLC
